WallStreetZenWallStreetZen

NYSE: GMED
Globus Medical Inc Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Globus Medical earnings were $537.9M for the trailing 12 months ending Dec 31, 2025, with 423.7% growth year over year. The latest GMED earnings report on Dec 31, 2025 announced Q4 2025 earnings of $140.6M, up 18.2% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, GMED reported annual earnings of $537.9M, with 422.3% growth.

GMED past earnings growth

How has GMED's earnings growth performed historically?

Company
423.68%
Industry
23.7%
Market
87.05%
GMED's earnings have grown faster... subscribe to Premium to read more.
Earnings Growth vs Industry Performance
GMED's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Market Performance
GMED's earnings growth is accelerating... subscribe to Premium to read more.
Accelerating Earnings Growth Performance

GMED earnings history

Current Revenue
$2.9B
Current Earnings
$537.9M
Current Profit Margin
18.3%
GMED's has demonstrated consistent long-term... subscribe to Premium to read more.
Long-term Earnings Growth Trend Performance

GMED Return on Equity

Current Company
12.4%
Current Industry
9.1%
Current Market
29.2%
GMED's Return on Equity (12.4%)... subscribe to Premium to read more.
High Return on Equity Performance

GMED Return on Assets

Current Company
10.7%
Current Industry
5.6%
GMED is generating higher Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when GMED announces earnings.

GMED Return on Capital Employed

Current Company
12.45%
Current Industry
9.8%
GMED has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

GMED vs Medical Device Stocks

TickerEBITDAEarningsY/Y EarningsEPS
GMED$874.77M$537.87M+30.79%$3.98
ALGN$862.47M$410.35M-24.15%$5.66
PEN$222.60M$177.69M+139.03%$4.57
SNN$1.49B$625.00M+7.04%$1.44
MASI-$47.80M-$151.50MN/A-$2.83
View Top Medical Device Stocks

Globus Medical Earnings Reports & History FAQ

What were Globus Medical's earnings last quarter?

On GMED's earnings call on Invalid Date, Globus Medical (NYSE: GMED) reported Q4 2025 earnings per share (EPS) of $1.05, up 425% year over year. Total GMED earnings for the quarter were $140.59 million. In the same quarter last year, Globus Medical's earnings per share (EPS) was $0.20.

If you're new to stock investing, here's how to buy Globus Medical stock.

Is Globus Medical profitable or losing money?

As of the last Globus Medical earnings report, Globus Medical is currently profitable. Globus Medical's net profit (also called net income) for the twelve months ending Dec 31, 2025 was $537.87 million, a 422.28% increase year over year.

What was GMED's earnings growth in the past year?

As of Globus Medical's earnings date in Invalid Date, Globus Medical's earnings has grown 423.68% year over year. This is 399.99 percentage points higher than the US Medical Devices industry earnings growth rate of 23.7%. GMED earnings in the past year totalled $537.87 million.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.